PUBLISHED DATE : Mar 2023 | Pages : 327
Fill out your details & get your free sample
The Transport Media Market Size, Share, & Trends Analysis Report By
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2023–2028
327 Pages
159 Tables
130 Charts
5 Regions
18 Countries
50 Companies
5 Market Segment
| Report Attribute | Details |
|---|---|
| Market Size (2028) | USD 12.59 Billion |
| Market Size (2022) | USD 13.15 Billion |
| CAGR (2022-2028) | (0.73%) |
| Base Year | 2022 |
| Forecast Year | 2023-2028 |
| Market Segments | Product, Application, Indication, End-Users, and Geography |
| Geographic Analysis | North America, Europe, APAC, Latin America, and Middle East & Africa |
| KEY VENDORS | BD, Hardy Diagnostics, HiMedia Laboratories, Laboratory Corporation of America, Puritan Medica Products, Thermo Fisher Scientific, and Vircell |
The global transport media market was valued at USD 13.15 billion in 2022 and is expected to reach USD 12.59 billion by 2028 during the forecast period. Transport media are scientifically developed special media formulated to preserve a sample of bio-specimen and minimize bacterial overgrowth from the collection time to receive at a laboratory for further processing. Based on the type of organism suspected in the sample, transport media may be varied. The transport media market attributed the growth to various factors that constantly drive the market growth. In addition, several rapid changes occurred in the transport media development that delivered market growth opportunities for the forecast period.
Technological Advancement in Transport Media
During the COVID-19 pandemic, several advancements and new products have been launched in the transport media market. For several decades several transport media solutions have been introduced in the market to stabilize the specimen for the detection of microbial presence during the diagnostic investigation. From 2019 to 2022, some of the new products launched by various vendors were based on the high demand for diagnosing SARS-COV-2 viral infection. In addition, the development of formulations and advanced designs for appropriate sample collection increased the adoption of transport media and delivered lucrative market growth opportunities. In addition, the emerging monkeypox infectious disease is expected to drive the transport media market.
Several infectious disease outbreaks have significantly improved transport media solutions in recent years. Several new products are introduced with advanced and unique technologies to ease in detection and diagnosis of infected patients. Thermo Fisher Scientific designed a fully innovative non-hazardous virus inactivation medium that supports the safe collection and transport of the COVID-19 virus. In 2021, VIRCELL S.L. launched a new transport medium solution for pediatric clinical diagnostics for collecting and preserving various viruses. In addition, the increased funding for infectious diseases diagnosis and growing research towards viral transport media due to the COVID-19 pandemic deliver lucrative opportunities for transport media market growth.
Impact of COVID-19
The COVID-19 pandemic positively increased awareness about diagnosis and transport media relations among medical professionals and people, which drove the high demand for transport media. Also, the increasing production capacity of transport media solutions increases the high capacity of manufacturers. Most leading and emerging market players expand their manufacturing units with advanced facilities, expected to drive transport media market growth.
Increasing Prevalence of Infectious Diseases
In 2019, the viral infection SARS-COV-2 started to spread worldwide, and millions of people got infected as of November 2022. With the increasing prevalence of infectious diseases worldwide, the demand for transport media increased in detecting and diagnosing viral and non-viral infectious diseases. The emerging and re-emerging infectious diseases impacting human life cause millions of deaths annually. The growing burden of infectious diseases continuously increases the demand for transport media solutions and boosts market growth. The increasing diagnosis rate for infectious diseases is accelerating the transport media industry's growth. Globally, billions of lives are attributed to infectious diseases. The increasing awareness, rising healthcare expenditure, and growing access to health services resulted in the high demand for infectious disease cures, propelling the market growth.
INSIGHTS BY PRODUCT
The global transport media market by product is segmented into viral transport media, universal transport media, molecular transport media, and others. The other transport media segments included Cary & Blair medium, Amies medium, Stuarts medium, alkaline peptone water, and buffered glycerol saline. In 2022, the viral transport media segment accounted for a 55.75% higher industry share and dominated the other segments. The factors that increase the high revenue of viral transport media are the significant patient population infected with viral infectious diseases, significant diagnosis and testing done for COVID-19, and increasing awareness for diagnosis and pre-clinical diagnosis and testing. These factors significantly improved the viral transport media application rate and accelerated segmental growth. In the UK, the government has published and implemented guidelines to test monkeypox specimen samples and sample transporting through viral transport media.
INSIGHTS BY APPLICATION
The global transport media market by application is segmented into diagnosis and pre-clinical testing. The diagnosis segment accounted for a 65.75% higher market share in 2022 and dominated the application segment. Due to the increasing infectious diseases prevalence and the emergence of COVID-19, monkeypox, and influenza virus infection in developed and developing countries, the demand for diagnosis is increased, which resulted in high segmental growth. In developed regions such as North America and Europe, the pre-clinical testing rate is higher than in developing regions such as APAC, Latin America, & Middle East & Africa. North America and Europe are showing steady growth for pre-clinical testing and driving segmental growth.
INSIGHTS BY INDICATION
The viral diseases indication segment dominated the global transport media in 2022 and was valued at USD 9.74 million. The prevalence of viral infectious diseases such as influenza virus, herpes simplex virus, varicella zoster, respiratory syncytial virus, and other emerging such as monkeypox and already emerged COVID-19 infectious diseases drive high segmental growth. Moreover, COVID-19 and influenza are both contagious respiratory illnesses caused by different types of viruses, such as COVID-19 is caused by SARS-COV-2, and the influenza virus causes flu. Influenza and COVID-19 are considered severe public health concerns worldwide, impacting millions of lives. Since 2020, across the world, various public health and social measures have been implemented to mitigate the COVID-19 pandemic caused by SARS-COV-2. In 2022, the viral diseases segment accounted for a 74.05% market share in the global transport media market.
INSIGHTS BY END-USER
The diagnostics labs became a major health service from 2020 to 2022 due to COVID-19 and other infectious disease detection. Due to the increased demand for diagnosis and testing in the COVID-19 pandemic, diagnostic labs have become a major part of diagnosis and accounted for a higher transport media market share in 2022. The high number of COVID-19 detection tests and emerging demand for monkeypox and influenza virus burden in 2022 are accelerating the segmental growth. In addition, other infectious diseases constantly demanded early detection and diagnosis to boost segmental growth. However, the diagnostic lab's segment growth is expected to decrease with the decreasing demand for COVID-19 diagnosis. And the hospitals and clinics segment is expected to increase with a substantial growth rate during the forecast period. In 2022, the diagnostic lab segment accounted for 41.52% market share in the global transport media market.
North America dominated the transport media market and accounted for a 33.02% share in 2022. The increasing prevalence of viral infectious diseases and associated population, high diagnostic and pre-clinical testing rate, and increasing focus on research and development in the region on viral diseases boost the regional industry growth. The region's higher prevalence of infectious diseases continuously accelerates the diagnosis and testing demand, leading to an increased high requirement for transport media solutions. North America was one of the major regions affected by the SARS-COV-2 infection and delivered higher market growth by transport media solutions.
In Europe, the prevalence rate for infectious diseases is continuously increasing due to the vast population and rapid spread of infectious diseases among people. European countries face the challenges of preventing infectious diseases and how to allocate the best healthcare protection resources. The burden of infectious diseases is continuously increasing in the region. In May 2022, the European region declared an outbreak of monkeypox. In 2019, the emergence of the COVID-19 pandemic was declared by the European region. Moreover, the impact of seasonal influenza viruses and other infectious diseases constantly delivers a high burden in the European region, accelerating the transport media market growth.
The APAC transport media market was valued at USD 2.7 billion in 2022. The prevalence of infectious diseases is constantly increasing in the region, expected to drive industry growth during the forecast period. Infectious diseases such as viral and non-viral infections impact millions of lives in APAC. The viral and non-viral infectious disease patient population is relatively higher in APAC countries. China and India are the two major countries that demand better diagnosis and cure with a significant volume of the targeted patient population. Several domestic and global transport media market players came forward to fulfill the demand for transport media solutions and increase the competitive rivalry among major market players. The high infection rate, the emergence of new market players, research and development activities, and the high patient population are the major factors that accelerate regional industry growth.
The leading global transport media market players include BD, Puritan Medical, Thermo Fisher Scientific, Laboratory Corporation of America Holdings, Hardy Diagnostics, HiMedia Laboratories, and Vircell. The global industry is highly competitive, with local, domestic, regional, and global players worldwide. The market player's geographical presence and broad distribution channels make the market competitive through major supply, import, and export strategies. During the COVID-19 pandemic, the significantly increased demand for transport media drove high export and import in different countries through various market players.
Several new changes occurred in the industry, with leading companies adopting new business strategies. In the transport media market, some mergers and acquisitions were made to increase the production of transport media, which led to high competition. The increased number of emerging and small-sized manufacturing companies increase their business operations and deliver a significant volume of transport media. The companies' pioneers in viral transport media (VTM) accounted for higher competition due to the entrance of new industry players. In viral transport media manufacturing, BD (Beckton Dickinson), Thermo Fisher Scientific, Inc., Puritan Medical Products, Laboratory Corporation of America, Hardy Diagnostics, and other companies are being major support to enhance the production of VTM kits during the pandemic.
Frequently Asked Questions
How big is the transport media market?
The global transport media market size was valued at USD 13.15 billion in 2022 and is expected to reach USD 12.59 billion by 2028.
What is the projected CAGR of the transport media market during the forecast period?
The transport media market is expected to decline at a CAGR of (0.73%) during the forecast period.
Who are the key players in the global transport media market?
BD, Hardy Diagnostics, HiMedia Laboratories, Laboratory Corporation of America, Puritan Medica Products, Thermo Fisher Scientific, and Vircell are the key players in the global transport media market.
What are the growing trends in the transport media market?
The growing trends in the global transport media market are new products launched for transport media, technological advancement in transport media, rapid acceleration of diagnostics and funding during the pandemic, and increasing research & focus on viral transport media.
Which region holds the most significant global transport media market share?
North America dominated the global transport media market and accounted for a 33.02% share in 2022.
The global transport media market was valued at USD 13.15 billion in 2022 and is expected to reach USD 12.59 billion by 2028.
The following factors are likely to contribute to the growth of the transport media market during the forecast period:
Base Year: 2022
Forecast Year: 2023-2028
The report considers the present scenario of the transport media market and its market dynamics for 2023−2028. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the industry. It also profiles and analyzes leading companies and several other prominent companies operating in the industry.
Key Company Profiles
Other Prominent Vendors
Segmentation by Product
Segmentation by Application
Segmentation by Indication
Segmentation by End-users
Segmentation by Geography
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET BY PRODUCT SEGMENT
4.3.2 MARKET BY APPLICATION SEGMENT
4.3.3 MARKET BY INDICATION SEGMENT
4.3.4 MARKET BY END-USERS
4.3.5 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 PREMIUM INSIGHTS
6.1 OVERVIEW
7 MARKET AT A GLANCE
8 INTRODUCTION
8.1 OVERVIEW
9 MARKET OPPORTUNITIES & TRENDS
9.1 NEW PRODUCT LAUNCHED FOR TRANSPORT MEDIA
9.2 TECHNOLOGICAL ADVANCES IN TRANSPORT MEDIA
9.3 RAPID ACCELERATION OF DIAGNOSTICS AND FUNDING DURING PANDEMIC
9.4 INCREASING RESEARCH AND FOCUS ON VIRAL TRANSPORT MEDIA
10 MARKET GROWTH ENABLERS
10.1 IMPACTS OF COVID-19
10.2 INCREASING PREVALENCE OF INFECTIOUS DISEASES
10.3 INCREASING DIAGNOSIS RATE FOR INFECTIOUS DISEASES
11 MARKET RESTRAINTS
11.1 AVAILABLE ALTERNATIVE SOLUTIONS FOR TRANSPORT MEDIA
11.2 LIMITED ACCESS TO DIAGNOSTIC SERVICES IN LMICS
11.3 CHALLENGES ASSOCIATED WITH TRANSPORT MEDIA
12 MARKET LANDSCAPE
12.1 MARKET OVERVIEW
12.2 MARKET SIZE & FORECAST
12.2.1 INSIGHTS BY PRODUCT
12.2.2 INSIGHTS BY APPLICATION
12.2.3 INSIGHTS BY INDICATION
12.2.4 INSIGHTS BY END-USERS
12.2.5 INSIGHTS BY GEOGRAPHY
12.3 FIVE FORCES ANALYSIS
12.3.1 THREAT OF NEW ENTRANTS
12.3.2 BARGAINING POWER OF SUPPLIERS
12.3.3 BARGAINING POWER OF BUYERS
12.3.4 THREAT OF SUBSTITUTES
12.3.5 COMPETITIVE RIVALRY
13 PRODUCT
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 VIRAL TRANSPORT MEDIA (VTM)
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 MARKET BY GEOGRAPHY
13.4 UNIVERSAL TRANSPORT MEDIA (UTM)
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.4.3 MARKET BY GEOGRAPHY
13.5 MOLECULAR TRANSPORT MEDIA (MTM)
13.5.1 MARKET OVERVIEW
13.5.2 MARKET SIZE & FORECAST
13.5.3 MARKET BY GEOGRAPHY
13.6 OTHERS
13.6.1 MARKET OVERVIEW
13.6.2 MARKET SIZE & FORECAST
13.6.3 MARKET BY GEOGRAPHY
14 APPLICATION
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 DIAGNOSIS
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.3.3 MARKET BY GEOGRAPHY
14.4 PRECLINICAL TESTINGS
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.4.3 MARKET BY GEOGRAPHY
15 INDICATION
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 VIRAL DISEASES
15.3.1 MARKET OVERVIEW
15.3.2 MARKET SIZE & FORECAST
15.3.3 MARKET BY GEOGRAPHY
15.4 NON-VIRAL DISEASE
15.4.1 MARKET OVERVIEW
15.4.2 MARKET SIZE & FORECAST
15.4.3 MARKET BY GEOGRAPHY
16 END-USERS
16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 MARKET OVERVIEW
16.3 DIAGNOSTIC LABS
16.3.1 MARKET OVERVIEW
16.3.2 MARKET SIZE & FORECAST
16.3.3 MARKET BY GEOGRAPHY
16.4 HOSPITALS AND CLINICS
16.4.1 MARKET OVERVIEW
16.4.2 MARKET SIZE & FORECAST
16.4.3 MARKET BY GEOGRAPHY
16.5 OTHERS
16.5.1 MARKET OVERVIEW
16.5.2 MARKET SIZE & FORECAST
16.5.3 MARKET BY GEOGRAPHY
17 GEOGRAPHY
17.1 MARKET SNAPSHOT & GROWTH ENGINE
17.2 GEOGRAPHIC OVERVIEW
18 NORTH AMERICA
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.3 PRODUCT
18.3.1 MARKET SIZE & FORECAST
18.4 APPLICATION
18.4.1 MARKET SIZE & FORECAST
18.5 INDICATION
18.5.1 MARKET SIZE & FORECAST
18.6 END-USERS
18.6.1 MARKET SIZE & FORECAST
18.7 KEY COUNTRIES
18.7.1 US: MARKET SIZE & FORECAST
18.7.2 CANADA: MARKET SIZE & FORECAST
19 EUROPE
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.3 PRODUCT
19.3.1 MARKET SIZE & FORECAST
19.4 APPLICATION
19.4.1 MARKET SIZE & FORECAST
19.5 INDICATION
19.5.1 MARKET SIZE & FORECAST
19.6 END-USERS
19.6.1 MARKET SIZE & FORECAST
19.7 KEY COUNTRIES
19.7.1 UK: MARKET SIZE & FORECAST
19.7.2 ITALY: MARKET SIZE & FORECAST
19.7.3 FRANCE: MARKET SIZE & FORECAST
19.7.4 GERMANY: MARKET SIZE & FORECAST
19.7.5 SPAIN: MARKET SIZE & FORECAST
20 APAC
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.3 PRODUCT
20.3.1 MARKET SIZE & FORECAST
20.4 APPLICATION
20.4.1 MARKET SIZE & FORECAST
20.5 INDICATION
20.5.1 MARKET SIZE & FORECAST
20.6 END-USERS
20.6.1 MARKET SIZE & FORECAST
20.7 KEY COUNTRIES
20.7.1 CHINA: MARKET SIZE & FORECAST
20.7.2 JAPAN: MARKET SIZE & FORECAST
20.7.3 INDIA: MARKET SIZE & FORECAST
20.7.4 AUSTRALIA: MARKET SIZE & FORECAST
20.7.5 SOUTH KOREA: MARKET SIZE & FORECAST
21 LATIN AMERICA
21.1 MARKET OVERVIEW
21.2 MARKET SIZE & FORECAST
21.3 PRODUCT
21.3.1 MARKET SIZE & FORECAST
21.4 APPLICATION
21.4.1 MARKET SIZE & FORECAST
21.5 INDICATION
21.5.1 MARKET SIZE & FORECAST
21.6 END-USERS
21.6.1 MARKET SIZE & FORECAST
21.7 KEY COUNTRIES
21.7.1 BRAZIL: MARKET SIZE & FORECAST
21.7.2 MEXICO: MARKET SIZE & FORECAST
21.7.3 ARGENTINA: MARKET SIZE & FORECAST
22 MIDDLE EAST AFRICA
22.1 MARKET OVERVIEW
22.2 MARKET SIZE & FORECAST
22.3 PRODUCT
22.3.1 MARKET SIZE & FORECAST
22.4 APPLICATION
22.4.1 MARKET SIZE & FORECAST
22.5 INDICATION
22.5.1 MARKET SIZE & FORECAST
22.6 END-USERS
22.6.1 MARKET SIZE & FORECAST
22.7 KEY COUNTRIES
22.7.1 TURKEY: MARKET SIZE & FORECAST
22.7.2 SAUDI ARABIA: MARKET SIZE & FORECAST
22.7.3 SOUTH AFRICA: MARKET SIZE & FORECAST
23 COMPETITIVE LANDSCAPE
23.1 COMPETITION OVERVIEW
23.2 MARKET SHARE ANALYSIS
23.2.1 BD
23.2.2 HARDY DIAGNOSTICS
23.2.3 HIMEDIA LABORATORIES
23.2.4 LABORATORY CORPORATION OF AMERICA
23.2.5 PURITAN MEDICAL PRODUCTS
23.2.6 THERMO FISHER SCIENTIFIC
23.2.7 VIRCELL
24 KEY COMPANY PROFILES
24.1 BD
24.1.1 BUSINESS OVERVIEW
24.1.2 PRODUCT OFFERINGS
24.1.3 KEY STRATEGIES
24.1.4 KEY STRENGTHS
24.1.5 KEY OPPORTUNITIES
24.2 HARDY DIAGNOSTICS
24.2.1 BUSINESS OVERVIEW
24.2.2 PRODUCT OFFERINGS
24.2.3 KEY STRATEGIES
24.2.4 KEY STRENGTHS
24.2.5 KEY OPPORTUNITIES
24.3 HIMEDIA LABORATORIES
24.3.1 BUSINESS OVERVIEW
24.3.2 PRODUCT OFFERINGS
24.3.3 KEY STRATEGIES
24.3.4 KEY STRENGTHS
24.3.5 KEY OPPORTUNITIES
24.4 LABORATORY CORPORATION OF AMERICA
24.4.1 BUSINESS OVERVIEW
24.4.2 PRODUCT OFFERINGS
24.4.3 KEY STRATEGIES
24.4.4 KEY STRENGTHS
24.4.5 KEY OPPORTUNITIES
24.5 PURITAN MEDICAL PRODUCTS
24.5.1 BUSINESS OVERVIEW
24.5.2 PRODUCT OFFERINGS
24.5.3 KEY STRATEGIES
24.5.4 KEY STRENGTHS
24.5.5 KEY OPPORTUNITIES
24.6 THERMO FISHER SCIENTIFIC
24.6.1 BUSINESS OVERVIEW
24.6.2 THERMO FISHER SCIENTIFIC IN TRANSPORT MEDIA MARKET
24.6.3 PRODUCT OFFERINGS
24.6.4 KEY STRATEGIES
24.6.5 KEY STRENGTHS
24.6.6 KEY OPPORTUNITIES
24.7 VIRCELL
24.7.1 BUSINESS OVERVIEW
24.7.2 PRODUCT OFFERINGS
24.7.3 KEY STRATEGIES
24.7.4 KEY STRENGTHS
24.7.5 KEY OPPORTUNITIES
25 OTHER PROMINENT VENDORS
25.1 AB MEDICAL
25.1.1 BUSINESS OVERVIEW
25.1.2 PRODUCT OFFERINGS
25.2 ALPHA-TEC SYSTEMS
25.2.1 BUSINESS OVERVIEW
25.2.2 PRODUCT OFFERINGS
25.3 ACCUGENE USA
25.3.1 BUSINESS OVERVIEW
25.3.2 PRODUCT OFFERINGS
25.4 APICAL SCIENTIFIC
25.4.1 BUSINESS OVERVIEW
25.4.2 PRODUCT OFFERINGS
25.5 AZOOKA LABS
25.5.1 BUSINESS OVERVIEW
25.5.2 PRODUCT OFFERINGS
25.6 BIOMED DIAGNOSTICS
25.6.1 BUSINESS OVERVIEW
25.6.2 PRODUCT OFFERINGS
25.7 BIOBOAVISTA
25.7.1 BUSINESS OVERVIEW
25.7.2 PRODUCT OFFERINGS
25.8 BIOGENEX
25.8.1 BUSINESS OVERVIEW
25.8.2 PRODUCT OFFERINGS
25.9 BIOLOGIX GROUP
25.9.1 BUSINESS OVERVIEW
25.9.2 PRODUCT OFFERINGS
25.10 BIOCOMMA
25.10.1 BUSINESS OVERVIEW
25.10.2 PRODUCT OFFERINGS
25.11 CHARM SCIENCES
25.11.1 BUSINESS OVERVIEW
25.11.2 PRODUCT OFFERINGS
25.12 CREATIVE LIFE SCIENCES CO., LTD.
25.12.1 BUSINESS OVERVIEW
25.12.2 PRODUCT OFFERINGS
25.13 CITOTEST LABWARE MANUFACTURING
25.13.1 BUSINESS OVERVIEW
25.13.2 PRODUCT OFFERINGS
25.14 CPT MEDICAL
25.14.1 BUSINESS OVERVIEW
25.14.2 PRODUCT OFFERINGS
25.15 COPAN DIAGNOSTICS
25.15.1 BUSINESS OVERVIEW
25.15.2 PRODUCT OFFERINGS
25.16 DIASORIN MOLECULAR
25.16.1 BUSINESS OVERVIEW
25.16.2 PRODUCT OFFERINGS
25.17 EFK DIAGNOSTICS HOLDING
25.17.1 BUSINESS OVERVIEW
25.17.2 PRODUCT OFFERINGS
25.18 ENSOL BIOSCIENCES
25.18.1 BUSINESS OVERVIEW
25.18.2 PRODUCT OFFERINGS
25.19 GENERAL BIOLOGICS
25.19.1 BUSINESS OVERVIEW
25.19.2 PRODUCT OFFERINGS
25.20 GENTUERI
25.20.1 BUSINESS OVERVIEW
25.20.2 PRODUCT OFFERINGS
25.21 HANG CHANG MEDIC
25.21.1 BUSINESS OVERVIEW
25.21.2 PRODUCT OFFERINGS
25.22 HEBEI CHAORAN MEDICAL INSTRUMENTS
25.22.1 BUSINESS OVERVIEW
25.22.2 PRODUCT OFFERINGS
25.23 INNOLYZER LABS
25.23.1 BUSINESS OVERVIEW
25.23.2 PRODUCT OFFERINGS
25.24 KSL DIAGNOSTICS
25.24.1 BUSINESS OVERVIEW
25.24.2 PRODUCT OFFERINGS
25.25 LUCENCE HEALTH
25.25.1 BUSINESS OVERVIEW
25.25.2 PRODUCT OFFERINGS
25.26 LAUNCHWORKS
25.26.1 BUSINESS OVERVIEW
25.26.2 PRODUCT OFFERINGS
25.27 LIOFILCHEM
25.27.1 BUSINESS OVERVIEW
25.27.2 PRODUCT OFFERINGS
25.28 MEDICAL WIRE & EQUIPMENT
25.28.1 BUSINESS OVERVIEW
25.28.2 PRODUCT OFFERINGS
25.29 MIRACLEAN TECHNOLOGY
25.29.1 BUSINESS OVERVIEW
25.29.2 PRODUCT OFFERINGS
25.30 METADESIGN SOLUTIONS
25.30.1 BUSINESS OVERVIEW
25.30.2 PRODUCT OFFERINGS
25.31 QUIDEL CORPORATION
25.31.1 BUSINESS OVERVIEW
25.31.2 PRODUCT OFFERINGS
25.32 TRINITY BIOTECH
25.32.1 BUSINESS OVERVIEW
25.32.2 PRODUCT OFFERINGS
25.33 MANILA HEALTHTEK
25.33.1 BUSINESS OVERVIEW
25.33.2 PRODUCT OFFERINGS
25.34 MATTEK
25.34.1 BUSINESS OVERVIEW
25.34.2 PRODUCT OFFERINGS
25.35 NODFORD INTERNATIONAL
25.35.1 BUSINESS OVERVIEW
25.35.2 PRODUCT OFFERINGS
25.36 STARPLEX SCIENTIFIC
25.36.1 BUSINESS OVERVIEW
25.36.2 PRODUCT OFFERINGS
25.37 SANSURE BIOTECH
25.37.1 BUSINESS OVERVIEW
25.37.2 PRODUCT OFFERINGS
25.38 SISCO RESEARCH LABORATORIES
25.38.1 BUSINESS OVERVIEW
25.38.2 PRODUCT OFFERINGS
25.39 TEKNOVA
25.39.1 BUSINESS OVERVIEW
25.39.2 PRODUCT OFFERINGS
25.40 TITAN BIOTECH
25.40.1 BUSINESS OVERVIEW
25.40.2 PRODUCT OFFERINGS
25.41 VEGAS BIOTECH
25.41.1 BUSINESS OVERVIEW
25.41.2 PRODUCT OFFERINGS
25.42 YOCON BIOLOGY TECHNOLOGY COMPANY
25.42.1 BUSINESS OVERVIEW
25.42.2 PRODUCT OFFERINGS
25.43 ZYBIO
25.43.1 BUSINESS OVERVIEW
25.43.2 PRODUCT OFFERINGS
26 REPORT SUMMARY
26.1 KEY TAKEAWAYS
26.2 STRATEGIC RECOMMENDATIONS
27 QUANTITATIVE SUMMARY
27.1 MARKET BY GEOGRAPHY
27.2 MARKET BY PRODUCT
27.3 MARKET BY APPLICATION
27.4 MARKET BY INDICATION
27.5 MARKET BY END-USERS
27.6 PRODUCT: MARKET BY GEOGRAPHY
27.6.1 VIRAL TRANSPORT MEDIA: MARKET BY GEOGRAPHY
27.6.2 UNIVERSAL TRANSPORT MEDIA: MARKET BY GEOGRAPHY
27.6.3 MOLECULAR TRANSPORT MEDIA: MARKET BY GEOGRAPHY
27.6.4 OTHER TRANSPORT MEDIA: MARKET BY GEOGRAPHY
27.7 APPLICATION: MARKET BY GEOGRAPHY
27.7.1 DIAGNOSIS: MARKET BY GEOGRAPHY
27.7.2 PRE-CLINICAL TESTING: MARKET BY GEOGRAPHY
27.8 INDICATION: MARKET BY GEOGRAPHY
27.8.1 VIRAL DISEASE: MARKET BY GEOGRAPHY
27.8.2 NON-VIRAL DISEASE: MARKET BY GEOGRAPHY
27.9 END-USERS: MARKET BY GEOGRAPHY
27.9.1 DIAGNOSTIC LABS: MARKET BY GEOGRAPHY
27.9.2 HOSPITALS & CLINICS: MARKET BY GEOGRAPHY
27.9.3 OTHER END-USERS: MARKET BY GEOGRAPHY
28 APPENDIX
28.1 ABBREVIATIONS
EXHIBIT 1 SEGMENTATION OF GLOBAL TRANSPORT MEDIA MARKET
EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2022
EXHIBIT 3 TYPES OF TRANSPORT MEDIA
EXHIBIT 4 IMPACT OF NEW PRODUCT LAUNCHED FOR TRANSPORT MEDIA
EXHIBIT 5 IMPACT OF TECHNOLOGICAL ADVANCES IN TRANSPORT MEDIA
EXHIBIT 6 IMPACT OF RAPID ACCELERATION OF DIAGNOSTICS AND FUNDING DURING PANDEMIC
EXHIBIT 7 IMPACT OF INCREASING RESEARCH & FOCUS ON VIRAL TRANSPORT MEDIA
EXHIBIT 8 IMPACT OF IMPACTS OF COVID-19
EXHIBIT 9 IMPACTS OF COVID-19 ON TRANSPORT MEDIA MARKET
EXHIBIT 10 IMPACT OF INCREASING PREVALENCE OF INFECTIOUS DISEASES
EXHIBIT 11 IMPACT OF INCREASING DIAGNOSIS RATE FOR INFECTIOUS DISEASES
EXHIBIT 12 NON-VARIOLA ORTHOPOX/MONKEYPOX TESTING: VOLUME VS. CAPACITY
EXHIBIT 13 TOTAL COVID-19 TEST BY COUNTRIES (2020-2022)
EXHIBIT 14 NON-VARIOLA ORTHOPOX/ MONKEYPOX TESTING FROM PUBLIC AND SELECTED COMMERCIAL LABORATORIES (2022)
EXHIBIT 15 IMPACT OF AVAILABLE ALTERNATIVE SOLUTIONS FOR TRANSPORT MEDIA
EXHIBIT 16 IMPACT OF LIMITED ACCESS TO DIAGNOSTIC AND SERVICES IN LMICS
EXHIBIT 17 DIAGNOSTIC GAP FOR SOME HEALTH CONDITIONS (DATA BASED ON 16 DIFFERENT COUNTRIES 2021)
EXHIBIT 18 IMPACT OF CHALLENGES ASSOCIATED WITH TRANSPORT MEDIA
EXHIBIT 19 GLOBAL TRANSPORT MEDIA MARKET 2022–2028 ($ MILLION)
EXHIBIT 20 GLOBAL TRANSPORT MEDIA MARKET SHARE BY PRODUCT 2022 & 2028
EXHIBIT 21 GLOBAL TRANSPORT MEDIA MARKET SHARE BY APPLICATION 2022 & 2028
EXHIBIT 22 GLOBAL TRANSPORT MEDIA MARKET SHARE BY INDICATION 2022 & 2028
EXHIBIT 23 GLOBAL TRANSPORT MEDIA MARKET SHARE BY END-USERS 2022 & 2028
EXHIBIT 24 GLOBAL TRANSPORT MEDIA MARKET SHARE BY GEOGRAPHY 2022 & 2028
EXHIBIT 25 FIVE FORCES ANALYSIS 2022
EXHIBIT 26 INCREMENTAL GROWTH BY PRODUCT 2022 & 2028
EXHIBIT 27 GLOBAL TRANSPORT MEDIA MARKET BY PRODUCT (2022-2028)
EXHIBIT 28 TRANSPORT MEDIA MARKET BY PRODUCT: INCREMENTAL GROWTH
EXHIBIT 29 TRANSPORT MEDIA MARKET BY PRODUCT: ABSOLUTE GROWTH
EXHIBIT 30 APPLICATION OF VIRAL TRANSPORT MEDIA
EXHIBIT 31 VIRAL TRANSPORT MEDIA MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 32 GLOBAL VIRAL TRANSPORT MEDIA MARKET 2022–2028 ($ MILLION)
EXHIBIT 33 ADVANTAGES DELIVERED BY SUBJECT UNIVERSAL TRANSPORT MEDIUM INCLUDES
EXHIBIT 34 UNIVERSAL TRANSPORT MEDIA MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 35 GLOBAL UNIVERSAL TRANSPORT MEDIA MARKET 2022–2028 ($ MILLION)
EXHIBIT 36 MOLECULAR TRANSPORT MEDIA ADVANTAGES & CAPABILITIES
EXHIBIT 37 MOLECULAR TRANSPORT MEDIA THAT INACTIVATES MICROBES AND VIRUSES
EXHIBIT 38 MOLECULAR TRANSPORT MEDIA MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 39 GLOBAL MOLECULAR TRANSPORT MEDIA MARKET 2022–2028 ($ MILLION)
EXHIBIT 40 OTHERS TRANSPORT MEDIA MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 41 GLOBAL OTHERS TRANSPORT MEDIA MARKET 2022–2028 ($ MILLION)
EXHIBIT 42 INCREMENTAL GROWTH BY APPLICATION 2022 & 2028
EXHIBIT 43 GLOBAL TRANSPORT MEDIA MARKET BY APPLICATION 2022-2028
EXHIBIT 44 TRANSPORT MEDIA MARKET BY APPLICATION: INCREMENTAL GROWTH
EXHIBIT 45 TRANSPORT MEDIA MARKET BY APPLICATION: ABSOLUTE GROWTH
EXHIBIT 46 TRANSPORT MEDIA MARKET BY DIAGNOSIS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 47 GLOBAL TRANSPORT MEDIA MARKET BY DIAGNOSIS 2022–2028 ($ MILLION)
EXHIBIT 48 TRANSPORT MEDIA MARKET BY PRE-CLINICAL TESTING: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 49 GLOBAL TRANSPORT MEDIA MARKET BY PRE-CLINICAL TESTING 2022–2028 ($ MILLION)
EXHIBIT 50 INCREMENTAL GROWTH BY INDICATION 2022 & 2028
EXHIBIT 51 GLOBAL TRANSPORT MEDIA MARKET BY INDICATION 2022-2028
EXHIBIT 52 TRANSPORT MEDIA MARKET BY INDICATION: INCREMENTAL GROWTH
EXHIBIT 53 TRANSPORT MEDIA MARKET BY INDICATION: ABSOLUTE GROWTH
EXHIBIT 54 IMPACT OF COVID-19 POSITIVITY ON INFLUENZA CASES GLOBALLY (2022)
EXHIBIT 55 GLOBAL COVID-19 DAILY CASES (2022)
EXHIBIT 56 TRANSPORT MEDIA MARKET BY VIRAL DISEASE: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 57 GLOBAL TRANSPORT MEDIA MARKET BY VIRAL DISEASE 2022–2028 ($ MILLION)
EXHIBIT 58 NON-VIRAL DISEASES THAT SUGGEST COLLECT THROUGH TRANSPORT MEDIA
EXHIBIT 59 TRANSPORT MEDIA MARKET BY NON-VIRAL DISEASE: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 60 GLOBAL TRANSPORT MEDIA MARKET BY NON-VIRAL DISEASE 2022–2028 ($ MILLION)
EXHIBIT 61 INCREMENTAL GROWTH BY END-USERS 2022 & 2028
EXHIBIT 62 GLOBAL TRANSPORT MEDIA MARKET BY END-USERS 2022-2028
EXHIBIT 63 TRANSPORT MEDIA MARKET BY END-USERS: INCREMENTAL GROWTH
EXHIBIT 64 TRANSPORT MEDIA MARKET BY END-USERS: ABSOLUTE GROWTH
EXHIBIT 65 TRANSPORT MEDIA MARKET BY DIAGNOSTIC LABS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 66 GLOBAL TRANSPORT MEDIA MARKET BY DIAGNOSTIC LABS 2022–2028 ($ MILLION)
EXHIBIT 67 NUMBER OF COVID-19 PATIENTS IN HOSPITALS JAN-2022 TO OCT-2022
EXHIBIT 68 TRANSPORT MEDIA MARKET BY HOSPITALS & CLINICS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 69 GLOBAL TRANSPORT MEDIA MARKET BY HOSPITALS & CLINICS 2022–2028 ($ MILLION)
EXHIBIT 70 TRANSPORT MEDIA MARKET BY OTHER END-USERS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 71 GLOBAL TRANSPORT MEDIA MARKET BY OTHER END-USERS 2022–2028 ($ MILLION)
EXHIBIT 72 INCREMENTAL GROWTH BY GEOGRAPHY 2022 & 2028
EXHIBIT 73 GLOBAL TRANSPORT MEDIA MARKET BY GEOGRAPHY (2022-2028)
EXHIBIT 74 TRANSPORT MEDIA MARKET BY GEOGRAPHY: INCREMENTAL GROWTH
EXHIBIT 75 TRANSPORT MEDIA MARKET BY GEOGRAPHY: ABSOLUTE GROWTH
EXHIBIT 76 NORTH AMERICA TRANSPORT MEDIA MARKET: KEY COUNTRIES
EXHIBIT 77 NORTH AMERICA TRANSPORT MEDIA MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 78 TRANSPORT MEDIA MARKET IN NORTH AMERICA 2022–2028 ($ MILLION)
EXHIBIT 79 INCREMENTAL GROWTH IN NORTH AMERICA 2022 & 2028
EXHIBIT 80 VIRAL INFECTIOUS DISEASES PREVALENCE IN US
EXHIBIT 81 NUMBER OF LABS BY TYPE AND TEST VOLUME IN US (2015-2016)
EXHIBIT 82 US TRANSPORT MEDIA MARKET 2022–2028 ($ MILLION)
EXHIBIT 83 CANADA: TOTAL COVID-19 CASES IN 2022 (FROM 2020-2022)
EXHIBIT 84 CANADA COVID-19 TEST PER 1,000 PEOPLE
EXHIBIT 85 TRANSPORT MEDIA MARKET IN CANADA 2022–2028 ($ MILLION)
EXHIBIT 86 EUROPE TRANSPORT MEDIA MARKET: KEY COUNTRIES
EXHIBIT 87 EUROPE TRANSPORT MEDIA MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 88 TRANSPORT MEDIA MARKET IN EUROPE 2022–2028 ($ MILLION)
EXHIBIT 89 INCREMENTAL GROWTH IN EUROPE 2022 & 2028
EXHIBIT 90 FACTS ABOUT PATHOLOGY LABS IN ENGLAND (2022)
EXHIBIT 91 IMPORT OF VIRAL TRANSPORT MEDIA FROM US, BELGIUM, AND FROM OTHER COUNTRIES IN UK IN 2022 ($ MILLION)
EXHIBIT 92 UK TRANSPORT MEDIA MARKET 2022–2028 ($ MILLION)
EXHIBIT 93 TRANSPORT MEDIA MARKET IN ITALY 2022–2028 ($ MILLION)
EXHIBIT 94 TOTAL EXPENDITURE ON LABORATORY ANALYSIS IN FRANCE ($ BN) 2014 TO 2019
EXHIBIT 95 FRANCE DAILY NEW COVID-19 CASES IN 2022 (CASES CONSIDERED ON 5TH DAY OF MONTH)
EXHIBIT 96 TRANSPORT MEDIA MARKET IN FRANCE 2022–2028 ($ MILLION)
EXHIBIT 97 GERMANY: DAILY COUNT OF COVID-19 CASES (15TH DAY OF MONTH)
EXHIBIT 98 DAILY COVID-19 TESTS DONE PER THOUSAND PEOPLE IN GERMANY FROM JAN 2022 TO JUN-2022
EXHIBIT 99 TRANSPORT MEDIA MARKET IN GERMANY 2022–2028 ($ MILLION)
EXHIBIT 100 SPAIN: COVID-19 DAILY CASES (2022)
EXHIBIT 101 TRANSPORT MEDIA MARKET IN SPAIN 2022–2028 ($ MILLION)
EXHIBIT 102 APAC TRANSPORT MEDIA MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 103 APAC TRANSPORT MEDIA MARKET: KEY COUNTRIES
EXHIBIT 104 TRANSPORT MEDIA MARKET IN APAC 2022–2028 ($ MILLION)
EXHIBIT 105 INCREMENTAL GROWTH IN APAC 2022 & 2028
EXHIBIT 106 TRANSPORT MEDIA MARKET IN CHINA 2022–2028 ($ MILLION)
EXHIBIT 107 JAPAN: THE PREVALENCE FOR PCR POSITIVITY (2022)
EXHIBIT 108 TRANSPORT MEDIA MARKET IN JAPAN 2022–2028 ($ MILLION)
EXHIBIT 109 TRANSPORT MEDIA MARKET IN INDIA 2022–2028 ($ MILLION)
EXHIBIT 110 TRANSPORT MEDIA MARKET IN AUSTRALIA 2022–2028 ($ MILLION)
EXHIBIT 111 TRANSPORT MEDIA MARKET IN SOUTH KOREA 2022–2028 ($ MILLION)
EXHIBIT 112 LATIN AMERICA TRANSPORT MEDIA MARKET: KEY COUNTRIES
EXHIBIT 113 LATIN AMERICA TRANSPORT MEDIA MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 114 TRANSPORT MEDIA MARKET IN LATIN AMERICA 2022–2028 ($ MILLION)
EXHIBIT 115 INCREMENTAL GROWTH IN LATIN AMERICA 2022 & 2028
EXHIBIT 116 BRAZIL: GEOGRAPHIC DISTRIBUTION OF THERAPEUTIC DIAGNOSTIC SUPPORT SERVICES & TYPE OF PROVIDER
EXHIBIT 117 TRANSPORT MEDIA MARKET IN BRAZIL 2022–2028 ($ MILLION)
EXHIBIT 118 TRANSPORT MEDIA MARKET IN MEXICO 2022–2028 ($ MILLION)
EXHIBIT 119 TRANSPORT MEDIA MARKET IN ARGENTINA2022–2028 ($ MILLION)
EXHIBIT 120 HIGH ANNUAL INCIDENCE RATE OF RSV (2021)
EXHIBIT 121 MIDDLE EAST & AFRICA TRANSPORT MEDIA MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 122 MIDDLE EAST & AFRICA TRANSPORT MEDIA MARKET: KEY COUNTRIES
EXHIBIT 123 TRANSPORT MEDIA MARKET IN MIDDLE EAST & AFRICA 2022–2028 ($ MILLION)
EXHIBIT 124 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2022 & 2028
EXHIBIT 125 TRANSPORT MEDIA MARKET IN TURKEY 2022–2028 ($ MILLION)
EXHIBIT 126 TRANSPORT MEDIA MARKET IN SAUDI ARABIA 2022–2028 ($ MILLION)
EXHIBIT 127 TRANSPORT MEDIA MARKET IN SOUTH AFRICA 2022–2028 ($ MILLION)
EXHIBIT 128 PURE & DIVERSIFIED VENDORS IN TRANSPORT MEDIA MARKET
EXHIBIT 129 VENDORS OFFERING TRANSPORT MEDIA: CAPABILITIES & EXPERTISE ASSESSMENT
EXHIBIT 130 VENDORS OFFERING TRANSPORT MEDIA: MARKET DOMINANCE ANALYSIS (2022)
LIST OF TABLES
TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2015−2022
TABLE 3 NEWLY LAUNCHED TRANSPORT MEDIUM SOLUTIONS
TABLE 4 PRIMESTORE MTM EFFECTIVENESS
TABLE 5 VIRAL TRANSPORT MEDIUM AVAILABILITY IN TWO FORMATS
TABLE 6 MONKEYPOX CASES STATISTICS 2022 (MAJOR IMPACTING COUNTRIES) IN NOVEMBER FIRST WEEK
TABLE 7 VIRAL TRANSPORT MEDIA FOR MONKEYPOX SPECIMEN COLLECTION
TABLE 8 SWAB VALIDATION USING IN-HOUSE VTM
TABLE 9 VIRAL TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022−2028 ($ MILLION)
TABLE 10 VIRAL TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022−2028 (%)
TABLE 11 UNIVERSAL TRANSPORT MEDIA FOR MONKEYPOX SPECIMEN COLLECTION
TABLE 12 UNIVERSAL TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022−2028 ($ MILLION)
TABLE 13 UNIVERSAL TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022−2028 (%)
TABLE 14 LIST OF FEW MOLECULAR TRANSPORT MEDIA PRODUCTS
TABLE 15 MOLECULAR TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022−2028 ($ MILLION)
TABLE 16 MOLECULAR TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022−2028 (%)
TABLE 17 OTHERS TRANSPORT MEDIA WITH MANUFACTURERS AND TYPE
TABLE 18 OTHER TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022−2028 ($ MILLION)
TABLE 19 OTHER TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022−2028 (%)
TABLE 20 GLOBAL COVID-19 TEST DONE FOR DIAGNOSIS FROM 2019 TO 2022 (NOVEMBER 2022)
TABLE 21 DIAGNOSIS SEGMENT TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022−2028 ($ MILLION)
TABLE 22 DIAGNOSIS SEGMENT TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022−2028 (%)
TABLE 23 PRE-CLINICAL TESTING TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022−2028 ($ MILLION)
TABLE 24 PRE-CLINICAL TESTING TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022−2028 (%)
TABLE 25 VIRAL DISEASE TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022−2028 ($ MILLION)
TABLE 26 VIRAL DISEASE TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022−2028 (%)
TABLE 27 NON-VIRAL DISEASE TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022−2028 ($ MILLION)
TABLE 28 NON-VIRAL DISEASE TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022−2028 (%)
TABLE 29 DIAGNOSTIC LABS TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022−2028 ($ MILLION)
TABLE 30 DIAGNOSTIC LABS TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022−2028 (%)
TABLE 31 HOSPITALS & CLINICS TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022−2028 ($ MILLION)
TABLE 32 HOSPITALS AND CLINICS TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022−2028 (%)
TABLE 33 OTHER END-USER TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022−2028 ($ MILLION)
TABLE 34 OTHER END-USER TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022−2028 (%)
TABLE 35 MONKEYPOX REPORTING CASES 2022
TABLE 36 NORTH AMERICA TRANSPORT MEDIA MARKET BY PRODUCT 2022−2028 ($ MILLION)
TABLE 37 NORTH AMERICA TRANSPORT MEDIA MARKET BY PRODUCT 2022−2028 (%)
TABLE 38 NORTH AMERICA TRANSPORT MEDIA MARKET BY APPLICATION 2022−2028 ($ MILLION)
TABLE 39 NORTH AMERICA TRANSPORT MEDIA MARKET BY APPLICATION 2022−2028 (%)
TABLE 40 NORTH AMERICA TRANSPORT MEDIA MARKET BY INDICATION 2022−2028 ($ MILLION)
TABLE 41 NORTH AMERICA TRANSPORT MEDIA MARKET BY INDICATION 2022−2028 (%)
TABLE 42 NORTH AMERICA TRANSPORT MEDIA MARKET BY END-USERS 2022−2028 ($ MILLION)
TABLE 43 NORTH AMERICA TRANSPORT MEDIA MARKET BY END-USERS 2022−2028 (%)
TABLE 44 MAJOR MARKET PLAYERS OPERATING IN US
TABLE 45 CANADA SWAB & VIRAL TRANSPORT MEDIUM SET IMPORT STATISTICS 2019 (PRODUCT CODE 382100 & QUANTITY UNIT KG)
TABLE 46 EUROPE TRANSPORT MEDIA MARKET BY PRODUCT 2022−2028 ($ MILLION)
TABLE 47 EUROPE TRANSPORT MEDIA MARKET BY PRODUCT 2022−2028 (%)
TABLE 48 EUROPE TRANSPORT MEDIA MARKET BY APPLICATION 2022−2028 ($ MILLION)
TABLE 49 EUROPE TRANSPORT MEDIA MARKET BY APPLICATION 2022−2028 (%)
TABLE 50 EUROPE TRANSPORT MEDIA MARKET BY INDICATION 2022−2028 ($ MILLION)
TABLE 51 EUROPE TRANSPORT MEDIA MARKET BY INDICATION 2022−2028 (%)
TABLE 52 EUROPE TRANSPORT MEDIA MARKET BY END-USERS 2022−2028 ($ MILLION)
TABLE 53 EUROPE TRANSPORT MEDIA MARKET BY END-USERS 2022−2028 (%)
TABLE 54 APAC TRANSPORT MEDIA MARKET BY PRODUCT 2022−2028 ($ MILLION)
TABLE 55 APAC TRANSPORT MEDIA MARKET BY PRODUCT 2022−2028 (%)
TABLE 56 APAC TRANSPORT MEDIA MARKET BY APPLICATION 2022−2028 ($ MILLION)
TABLE 57 APAC TRANSPORT MEDIA MARKET BY APPLICATION 2022−2028 (%)
TABLE 58 APAC TRANSPORT MEDIA MARKET BY INDICATION 2022−2028 ($ MILLION)
TABLE 59 APAC TRANSPORT MEDIA MARKET BY INDICATION 2022−2028 (%)
TABLE 60 APAC TRANSPORT MEDIA MARKET BY END-USER 2022−2028 ($ MILLION)
TABLE 61 APAC TRANSPORT MEDIA MARKET BY END-USER 2022−2028 (%)
TABLE 62 LATIN AMERICA TRANSPORT MEDIA MARKET BY PRODUCT 2022−2028 ($ MILLION)
TABLE 63 LATIN AMERICA TRANSPORT MEDIA MARKET BY PRODUCT 2022−2028 (%)
TABLE 64 LATIN AMERICA TRANSPORT MEDIA MARKET BY APPLICATION 2022−2028 ($ MILLION)
TABLE 65 LATIN AMERICA TRANSPORT MEDIA MARKET BY APPLICATION 2022−2028 (%)
TABLE 66 LATIN AMERICA TRANSPORT MEDIA MARKET BY INDICATION 2022−2028 ($ MILLION)
TABLE 67 LATIN AMERICA TRANSPORT MEDIA MARKET BY INDICATION 2022−2028 (%)
TABLE 68 LATIN AMERICA TRANSPORT MEDIA MARKET BY END-USERS 2022−2028 ($ MILLION)
TABLE 69 LATIN AMERICA TRANSPORT MEDIA MARKET BY END-USER 2022−2028 (%)
TABLE 70 MIDDLE EAST & AFRICA TRANSPORT MEDIA MARKET BY PRODUCT 2022−2028 ($ MILLION)
TABLE 71 MIDDLE EAST & AFRICA TRANSPORT MEDIA MARKET BY PRODUCT 2022−2028 (%)
TABLE 72 MIDDLE EAST & AFRICA TRANSPORT MEDIA MARKET BY APPLICATION 2022−2028 ($ MILLION)
TABLE 73 MIDDLE EAST & AFRICA TRANSPORT MEDIA MARKET BY APPLICATION 2022−2028 (%)
TABLE 74 MIDDLE EAST & AFRICA TRANSPORT MEDIA MARKET BY INDICATION 2022−2028 ($ MILLION)
TABLE 75 MIDDLE EAST & AFRICA TRANSPORT MEDIA MARKET BY INDICATION 2022−2028 (%)
TABLE 76 MIDDLE EAST & AFRICA TRANSPORT MEDIA MARKET BY END-USER 2022−2028 ($ MILLION)
TABLE 77 MIDDLE EAST & AFRICA TRANSPORT MEDIA MARKET BY END-USER 2022−2028 (%)
TABLE 78 BD: MAJOR PRODUCT OFFERINGS
TABLE 79 HARDY DIAGNOSTICS: MAJOR PRODUCT OFFERINGS
TABLE 80 HIMEDIA LABORATORIES: MAJOR PRODUCT OFFERINGS
TABLE 81 LABORATORY CORPORATION OF AMERICA: MAJOR PRODUCT OFFERINGS
TABLE 82 PURITAN MEDICA PRODUCTS: MAJOR PRODUCT OFFERINGS
TABLE 83 THERMO FISHER SCIENTIFIC: MAJOR PRODUCT OFFERINGS
TABLE 84 VIRCELL: MAJOR PRODUCT OFFERINGS
TABLE 85 AB MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 86 ALPHA-TEC SYSTEMS: MAJOR PRODUCT OFFERINGS
TABLE 87 ACCUGENE USA: MAJOR PRODUCT OFFERINGS
TABLE 88 APICAL SCIENTIFIC: MAJOR PRODUCT OFFERINGS
TABLE 89 AZOOKA LABS: MAJOR PRODUCT OFFERINGS
TABLE 90 BIOMED DIAGNOSTICS: MAJOR PRODUCT OFFERINGS
TABLE 91 BIOBOAVISTA: MAJOR PRODUCT OFFERINGS
TABLE 92 BIOGENEX: MAJOR PRODUCT OFFERINGS
TABLE 93 BIOLOGIX GROUP: MAJOR PRODUCT OFFERINGS
TABLE 94 BIOCOMMA: MAJOR PRODUCT OFFERINGS
TABLE 95 CHARM SCIENCES: MAJOR PRODUCT OFFERINGS
TABLE 96 CREATIVE LIFE SCIENCES.: MAJOR PRODUCT OFFERINGS
TABLE 97 CITOTEST LABWARE MANUFACTURING: MAJOR PRODUCT OFFERINGS
TABLE 98 CPT MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 99 COPAN DIAGNOSTICS: MAJOR PRODUCT OFFERINGS
TABLE 100 DIASORIN MOLECULAR: MAJOR PRODUCT OFFERINGS
TABLE 101 EKF DIAGNOSTICS HOLDING: MAJOR PRODUCT OFFERINGS
TABLE 102 ENSOL BIOSCIENCES: MAJOR PRODUCT OFFERINGS
TABLE 103 GENERAL BIOLOGICS: MAJOR PRODUCT OFFERINGS
TABLE 104 GENTUERI: MAJOR PRODUCT OFFERINGS
TABLE 105 HAN CHANG MEDIC: MAJOR PRODUCT OFFERINGS
TABLE 106 HEBEI CHAORAN MEDICAL INSTRUMENTS: MAJOR PRODUCT OFFERINGS
TABLE 107 INNOLYZER LABS: MAJOR PRODUCT OFFERINGS
TABLE 108 KSL DIAGNOSTICS: MAJOR PRODUCT OFFERINGS
TABLE 109 LUCENCE HEALTH: MAJOR PRODUCT OFFERINGS
TABLE 110 LAUNCHWORKS: MAJOR PRODUCT OFFERINGS
TABLE 111 LIOFILCHEM: MAJOR PRODUCT OFFERINGS
TABLE 112 MEDICAL WIRE & EQUIPMENT: MAJOR PRODUCT OFFERINGS
TABLE 113 MIRACLEAN TECHNOLOGY: MAJOR PRODUCT OFFERINGS
TABLE 114 METADESIGN SOLUTIONS: MAJOR PRODUCT OFFERINGS
TABLE 115 QUIDEL CORPORATION: MAJOR PRODUCT OFFERINGS
TABLE 116 TRINITY BIOTECH: MAJOR PRODUCT OFFERINGS
TABLE 117 MANILA HEALTHTEK: MAJOR PRODUCT OFFERINGS
TABLE 118 MATTEK: MAJOR PRODUCT OFFERINGS
TABLE 119 NODFORD INTERNATIONAL: MAJOR PRODUCT OFFERINGS
TABLE 120 STARPLEX SCIENTIFIC: MAJOR PRODUCT OFFERINGS
TABLE 121 SANSURE BIOTECH: MAJOR PRODUCT OFFERINGS
TABLE 122 SISCO RESEARCH LABORATORIES: MAJOR PRODUCT OFFERINGS
TABLE 123 TEKNOVA: MAJOR PRODUCT OFFERINGS
TABLE 124 TITAN BIOTECH: MAJOR PRODUCT OFFERINGS
TABLE 125 VEGAS BIOTECH: MAJOR PRODUCT OFFERINGS
TABLE 126 YOCON BIOLOGY TECHNOLOGY COMPANY: MAJOR PRODUCT OFFERINGS
TABLE 127 ZYBIO: MAJOR PRODUCT OFFERINGS
TABLE 128 GLOBAL TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022−2028 ($ MILLION)
TABLE 129 GLOBAL TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022−2028 (%)
TABLE 130 GLOBAL TRANSPORT MEDIA MARKET BY PRODUCT 2022−2028 ($ MILLION)
TABLE 131 GLOBAL TRANSPORT MEDIA MARKET BY PRODUCT 2022−2028 (%)
TABLE 132 GLOBAL TRANSPORT MEDIA MARKET BY APPLICATION 2022−2028 ($ MILLION)
TABLE 133 GLOBAL TRANSPORT MEDIA MARKET BY APPLICATION 2022−2028 (%)
TABLE 134 GLOBAL TRANSPORT MEDIA MARKET BY INDICATION 2022−2028 ($ MILLION)
TABLE 135 GLOBAL TRANSPORT MEDIA MARKET BY INDICATION 2022−2028 (%)
TABLE 136 GLOBAL TRANSPORT MEDIA MARKET BY END-USERS 2022−2028 ($ MILLION)
TABLE 137 GLOBAL TRANSPORT MEDIA MARKET BY END-USERS 2022−2028 (%)
TABLE 138 VIRAL TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022−2028 ($ MILLION)
TABLE 139 VIRAL TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022−2028 (%)
TABLE 140 UNIVERSAL TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022−2028 ($ MILLION)
TABLE 141 UNIVERSAL TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022−2028 (%)
TABLE 142 MOLECULAR TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022−2028 ($ MILLION)
TABLE 143 MOLECULAR TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022−2028 (%)
TABLE 144 OTHER TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022−2028 ($ MILLION)
TABLE 145 OTHERS TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022−2028 (%)
TABLE 146 DIAGNOSIS TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022−2028 ($ MILLION)
TABLE 147 DIAGNOSIS TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022−2028 (%)
TABLE 148 PRE-CLINICAL TESTING TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022−2028 ($ MILLION)
TABLE 149 PRE-CLINICAL TESTING TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022−2028 (%)
TABLE 150 VIRAL DISEASE TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022−2028 ($ MILLION)
TABLE 151 VIRAL DISEASE TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022−2028 (%)
TABLE 152 NON-VIRAL DISEASE TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022−2028 ($ MILLION)
TABLE 153 NON-VIRAL DISEASE TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022−2028 (%)
TABLE 154 DIAGNOSTIC LABS TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022−2028 ($ MILLION)
TABLE 155 DIAGNOSTIC LABS TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022−2028 (%)
TABLE 156 HOSPITALS & CLINICS TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022−2028 ($ MILLION)
TABLE 157 HOSPITALS & CLINICS TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022−2028 (%)
TABLE 158 OTHER END-USERS TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022−2028 ($ MILLION)
TABLE 159 OTHER END-USERS TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022−2028 (%)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
